Insulin glargine Clinical Trials

• Insulin Glulisine Administered Premeal Vs Postmeal in Adult Subjects with Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
  ClinicalTrials.gov Identifier: NCT00135096 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effects of Exenatide and Insulin Glargine in Subjects with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00097500 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00469092 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00095082 - Completed
  Diabetes Mellitus, Type I
  
• Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects with Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes
  ClinicalTrials.gov Identifier: NCT00135941 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glulisine Administered in a Fixed Bolus Regimen Vs Variable Bolus Regimen Based on Carbohydrate Counting in Adult Subjects with Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
  ClinicalTrials.gov Identifier: NCT00135057 - Completed
  Diabetes Mellitus, Type 2
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00467376 - Recruiting
  Diabetes Mellitus
  
• Comparing Pre-mixed Insulin with Insulin Glargine Combined with Rapid-acting Insulin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00110370 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00097084 - Completed
  Diabetes Mellitus, Type II
  
• Perioperative Insulin Glargine Dosing Study
  ClinicalTrials.gov Identifier: NCT00309465 - Recruiting
  Diabetes; Surgery
  
• Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells
  ClinicalTrials.gov Identifier: NCT00523393 - Recruiting
  Type 2 Diabetes
  
• TARGET: Insulin Glargine in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00347100 - Recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glargine "All to Target" Trial
  ClinicalTrials.gov Identifier: NCT00384085 - Recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glargine Vs Standard Insulin Therapy
  ClinicalTrials.gov Identifier: NCT00222521 - Completed
  Cystic Fibrosis Related Diabetes
  
• Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
  ClinicalTrials.gov Identifier: NCT00562172 - Recruiting
  Type 2 Diabetes Mellitus
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine.
  ClinicalTrials.gov Identifier: NCT00468754 - Completed
  Diabetes Mellitus, Type 1
  
• Comparison of the Ability of Glulisine with Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00115570 - Completed
  Diabetes Mellitus, Insulin-Dependent
  
• Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00437112 - Recruiting
  Type 2 Diabetes
  
• A 3 Month, Randomized, Open Label, Multi-Center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine
  ClinicalTrials.gov Identifier: NCT00539396 - Completed
  Diabetes Mellitus, Type 1
  
• Comparative Trial Between Insulin Glargine Plus Apidra Versus Sliding Scale Regular Insulin In Hospitalized Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00394407 - Completed
  Diabetes; Hyperglycemia
  
• Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00468364 - Completed
  Diabetes
  
• A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00457093 - Recruiting
  Type 2 Diabetes
  
• Use of Insulin Glargine to Treat Diabetic Ketoacidosis
  ClinicalTrials.gov Identifier: NCT00179127 - Recruiting
  Diabetic Ketoacidosis
  
• Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00174824 - Completed
  Diabetes Mellitus, Type 2
  
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00283751 - Completed
  Type 2 Diabetes Mellitus
  
• LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00423215 - Recruiting
  Diabetes Mellitus, Type 2
  
• Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00184613 - Completed
  Diabetes Mellitus, Type 2
  
• Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00312104 - Completed
  Type 1 Diabetes
  
• LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00349986 - Recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glargine During and After the Period of Fasting in Ramadan
  ClinicalTrials.gov Identifier: NCT00258804 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus
  ClinicalTrials.gov Identifier: NCT00565162 - Completed
  Diabetes Mellitus
  
• Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00184626 - Completed
  Diabetes Mellitus, Type 2
  
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00428207 - Recruiting
  Type 1 Diabetes Mellitus
  
• Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
  ClinicalTrials.gov Identifier: NCT00177398 - Completed
  Type 2 Diabetes; Hyperglycemia
  
• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00184600 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Inhaled Insulin Compared with Subcutaneous Human Insulin Therapy in Adults with Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00137046 - Active, not recruiting
  Diabetes Mellitus
  
• Efficacy and Safety of Inhaled Insulin Compared with Subcutaneous Human Insulin Therapy in Adults with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00136916 - Active, not recruiting
  Diabetes Mellitus
  
• Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as Add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
  ClinicalTrials.gov Identifier: NCT00384215 - Completed
  Diabetes Mellitus, Type 2
  
• Study of Recombinant Human Insulin-Like Growth Factor I in Patients with Severe Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00004419 - Recruiting
  Insulin Resistance; Hyperglycemia
  
• A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men
  ClinicalTrials.gov Identifier: NCT00347542 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent; Obesity
  
• Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00545805 - Enrolling by invitation
  Insulin Resistance; Obesity; Metabolic Syndrome X
  
• Insulin Glargine v Rosiglitazone as Add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
  ClinicalTrials.gov Identifier: NCT00358124 - Completed
  Type 2 Diabetes Mellitus
  
• Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
  ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
  Type 1 diabetes mellitus
  
• The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure
  ClinicalTrials.gov Identifier: NCT00549536 - Active, not recruiting
  Hypertension; Diabetes; Insulin Resistance
  
• Insulin Treatment Variation in Southwestern Diabetics
  ClinicalTrials.gov Identifier: NCT00148304 - Active, not recruiting
  Diabetes; Insulin; Blood Glucose Monitoring
  
• Insulin on Post Burn Hypermetabolism
  ClinicalTrials.gov Identifier: NCT00137254 - Active, not recruiting
  Burns
  
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
  ClinicalTrials.gov Identifier: NCT00211536 - Active, not recruiting
  Type 1 Diabetes
  
• Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
  ClinicalTrials.gov Identifier: NCT00099619 - Completed
  Type 2 Diabetes Mellitus
  
• Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
  ClinicalTrials.gov Identifier: NCT00258128 - Active, not recruiting
  Insulin Resistance
  
• Study of Response in CHC Patients Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (Study P04823)
  ClinicalTrials.gov Identifier: NCT00493805 - Recruiting
  Hepatitis C, Chronic; Insulin Resistance; Homeostasis Model Assessment of Insulin Resistance
  
• Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00085982 - Recruiting
  Insulin Resistance
  
• A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00467649 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics (BARI 2D)
  ClinicalTrials.gov Identifier: NCT00006305 - Active, not recruiting
  Coronary Disease; Cardiovascular Diseases; Heart Diseases; Insulin Resistance; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent
  
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
  ClinicalTrials.gov Identifier: NCT00564018 - Enrolling by invitation
  Type 1 Diabetes
  
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00402909 - Completed
  Type 2 Diabetes
  
• A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00240253 - Completed
  Type 2 Diabetes Mellitus
  
• Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
  ClinicalTrials.gov Identifier: NCT00518427 - Active, not recruiting
  Diabetes Type 2
  
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
  ClinicalTrials.gov Identifier: NCT00329225 - Active, not recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00435019 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00440284 - Active, not recruiting
  Type 2 Diabetes
  
• Influence of Insulin on BP Change During Adolescence
  ClinicalTrials.gov Identifier: NCT00007098 - Active, not recruiting
  Cardiovascular Diseases; Hypertension; Obesity; Insulin Resistance; Diabetes Mellitus
  
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
  ClinicalTrials.gov Identifier: NCT00309244 - Recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Growth Hormone on Insulin Signaling in Muscle Tissue
  ClinicalTrials.gov Identifier: NCT00477997 - Recruiting
  Insulin Resistance
  
• Metabolic Studies- Interactions Between GH and Insulin in GHDA
  ClinicalTrials.gov Identifier: NCT00568568 - Recruiting
  Insulin Resistance
  
• Treating the Endothelium to Restore Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00402194 - Recruiting
  Obesity; Insulin Resistance; Dysglycemia/Pre-Diabetes
  
• Effect of EGCG on the Body's Response to Insulin
  ClinicalTrials.gov Identifier: NCT00434499 - Recruiting
  Hypertension; Obesity; Type 2 Diabetes; Insulin Resistance
  
• Exercise in Insulin-Resistant Minority Adolescents
  ClinicalTrials.gov Identifier: NCT00345436 - Recruiting
  Insulin-Resistance
  
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332488 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Prenatal Nutrition and Adult Disease
  ClinicalTrials.gov Identifier: NCT00024583 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent; Insulin Resistance; Obesity; Hypertension
  
• Dietary Protein and Insulin Sensitivity Study
  ClinicalTrials.gov Identifier: NCT00508937 - Recruiting
  Insulin Resistance; Type 2 Diabetes; Metabolic Syndrome; Cardiovascular Disease; Dyslipidemia
  
• Recombinant Human Insulin-Like Growth Factor (rhIGF-1)Treatment of Short Stature Associated with IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125190 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency; IGF-1
  
• South Danish Diabetes Study
  ClinicalTrials.gov Identifier: NCT00121966 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
  ClinicalTrials.gov Identifier: NCT00188773 - Recruiting
  Insulin Resistance Syndrome X; Pancreatic Beta Cell Function
  
• Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
  ClinicalTrials.gov Identifier: NCT00004572 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00286962 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00185705 - Recruiting
  Hypertension; Insulin Resistance; Dyslipidemia
  
• Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
  ClinicalTrials.gov Identifier: NCT00006505 - Active, not recruiting
  Insulin Dependent Diabetes Mellitus
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004699 - Active, not recruiting
  Hyperinsulinism
  
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00338949 - Recruiting
  Schizophrenia; Metabolic Syndrome X; Insulin Resistance
  
• Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
  ClinicalTrials.gov Identifier: NCT00259168 - Recruiting
  Insulin Resistance; Impaired Fasting Glucose
  
• The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance
  ClinicalTrials.gov Identifier: NCT00172614 - Recruiting
  Metabolic Syndrome X; Cachexia; Insulin Resistance
  
• Insulin Glargine in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00268645 - Completed
  Diabetes Mellitus, Type 2
  
• Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
  ClinicalTrials.gov Identifier: NCT00394524 - Recruiting
  Diabetes or With New Hyperglycemia
  
• Dietary Advanced Glycation End-Products and Insulin Resistance in Overweight and Obese Humans
  ClinicalTrials.gov Identifier: NCT00422253 - Recruiting
  Type 2 Diabetes; Insulin Resistance; Obesity
  
• Rosiglitazone and Insulin Resistance in Renally Impaired Patients
  ClinicalTrials.gov Identifier: NCT00452166 - Recruiting
  Chronic Kidney Disease; Insulin Resistance
  
• Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant Adolescents
  ClinicalTrials.gov Identifier: NCT00493259 - Recruiting
  Insulin Resistance; Depression
  
• Study of Fat Cell Turnover in Subjects With and Without Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00560469 - Recruiting
  Adipocyte Differentiation; Insulin Resistance
  
• Characteristics of Glargine in Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00574912 - Recruiting
  Type 2 Diabetes
  
• The Role of Insulin Resistance in PCOS
  ClinicalTrials.gov Identifier: NCT00173043 - Recruiting
  Polycystic Ovary Syndrome; Insulin Resistance; Obesity
  
• Predicting Insulin Resistance in American Indian Youth
  ClinicalTrials.gov Identifier: NCT00498030 - Recruiting
  Insulin Resistance; Stress, Psychological
  
• Effects of Fish Oils on Inflammation and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00579436 - Recruiting
  Metabolic Syndrome; Insulin Resistance
  
• Insulin Resistance in Severely Obese Patients
  ClinicalTrials.gov Identifier: NCT00275223 - Recruiting
  Obesity; Insulin Resistance; Diabetes
  
• Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity
  ClinicalTrials.gov Identifier: NCT00443755 - Recruiting
  Type 2 Diabetes; Insulin Resistance
  
• Determine whether glycemic control is different between Lantus & a 3rd oral agent when failure with other treatment
  ClinicalTrials.gov Identifier: NCT00046462 - Completed
  Diabetes Mellitus
  
• SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00313937 - Completed
  Diabetes Mellitus, Type 1
  
• Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004700 - Active, not recruiting
  Hyperinsulinism
  
• Insulin Resistance in Non-Alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00252499 - Recruiting
  Insulin Resistance; Fatty Liver